ash 2018: using daratumumab early with standard myeloma combos for newly diagnosed patients
Published 5 years ago • 318 plays • Length 6:12Download video MP4
Download video MP3
Similar videos
-
1:38
ash 2018: dara/rev/dex/velcade for newly diagnosed multiple myeloma patients
-
8:26
ash 2018: selinexor, daratumumab and dexamethasone for relapsed/refractory myeloma
-
3:52
analysis of different clinical scenarios using daratumumab | rafael fonseca, md | ash 2021
-
7:31
clinical trial: darzalex (daratumamab) with revlimid/velcade/dex for newly diagnosed myeloma
-
1:30
ash 2018: treating relapsed/refractory myeloma with melflufan daratumamab
-
1:28
ash 2018: using exercise (even resistance training) in multiple myeloma patients
-
2:27
ash 2018: dara velcade dex with or without venetoclax
-
7:27
ash highlights: adding daratumumab to soc improves outcomes in multiple myeloma
-
14:28
all about darzalex (daratumumab) #myeloma
-
1:00:47
using daratumumab to treat high-risk myeloma patients
-
3:08
daratumumab for patients with multiple myeloma
-
4:19
multiple myeloma: frontline daratumumab combinations
-
6:07
griffin trial update - dvrd vs vrd in newly diagnosed myeloma | peter voorhees, md | ash 2021
-
3:20
clinical trial: daratumumab with rvd, peter voorhees, md, levine cancer institute
-
3:10
ash 2019: the save trial — early detection of amyloidosis | dr. ray comenzo
-
14:40
darzalex (daratumumab) - 2024 updated #myeloma
-
6:59
teclistamab in combination with sub-q daratumumab and lenalidomide in myeloma pts: majestec-2
-
3:19
revlimid refractory patients in daratumumab clinical trials | binod dhakal, md | ash 2022